Type 2 diabetics who use incretin-based drugs to treat the disease can breathe a sigh of relief. Recent research has found that these drugs do not elevate pancreatic cancer risks in those who use them on a regular basis. Concerns about pancreatic cancer and incretin-based drugs have existed for some time. The fear was that…

Researchers may have unlocked a way to better hone in on treatments that could be effective in the treatment of pancreatic cancer. This disease, considered among the deadliest forms of cancer, has a statistically significant low survival rate that has long vexed healthcare professionals. While major advances have increased survivability for many forms of cancer,…